Application Nr Approved Date Route Status External Links
BLA125561 None Intravenous None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Kanuma® Is Indicated For The Treatment Of Patients With A Diagnosis Of Lysosomal Acid Lipase (Lal) Deficiency. Kanuma® Is A Hydrolytic Lysosomal Cholesteryl Ester And Triacylglycerol-Specific Enzyme Indicated For The Treatment Of Patients With A Diagnosis Of Lysosomal Acid Lipase (Lal) Deficiency. ( 1 )

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Sebelipase Alfa

Comments